NuCoreBio

NuCore Bio is a South Korean biotechnology company focused on developing innovative cancer therapeutics by targeting the nucleosome, the fundamental unit of chromatin. The company utilizes its proprietary NuCore platform to identify and develop small molecule inhibitors that modulate epigenetic mechanisms involved in tumor progression and resistance. By focusing on the structural and functional aspects of the nucleosome core, NuCore Bio aims to create first-in-class treatments for various solid tumors and hematologic malignancies. The company's approach integrates structural biology and medicinal chemistry to address high unmet medical needs in the oncology space.